Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioLineRx
Biotech
BioLineRx forges joint cancer venture with Norwegian biotech
The Israeli drug developer will manage, fund and perform all development activities for GLIX1, a small-molecule glioblastoma candidate.
Darren Incorvaia
Sep 29, 2025 11:22am
BioLineRx financing; Ablynx fast track; Ophthotech pivot—News of Note
Jul 26, 2017 10:03am
Johnson & Johnson incubator gets dedicated VC fund
May 19, 2017 9:00am
EuroBiotech Report: AstraZeneca, Novartis, $30M round and more
Mar 23, 2017 9:49am
BioLineRx buys Agalimmune to expand cancer pipeline
Mar 23, 2017 8:48am
Microcap BioLineRx in-licenses second NASH candidate under Novartis deal
Sep 23, 2016 10:11am
